Targeted validation: validating clinical prediction models in their intended population and setting
- PMID: 36550534
- PMCID: PMC9773429
- DOI: 10.1186/s41512-022-00136-8
Targeted validation: validating clinical prediction models in their intended population and setting
Abstract
Clinical prediction models must be appropriately validated before they can be used. While validation studies are sometimes carefully designed to match an intended population/setting of the model, it is common for validation studies to take place with arbitrary datasets, chosen for convenience rather than relevance. We call estimating how well a model performs within the intended population/setting "targeted validation". Use of this term sharpens the focus on the intended use of a model, which may increase the applicability of developed models, avoid misleading conclusions, and reduce research waste. It also exposes that external validation may not be required when the intended population for the model matches the population used to develop the model; here, a robust internal validation may be sufficient, especially if the development dataset was large.
Keywords: Clinical prediction model; Generalisability; Validation.
© 2022. The Author(s).
Conflict of interest statement
The authors declare that they have no competing interests.
References
-
- Steyerberg EW. Clinical prediction models : a practical approach to development, validation, and updating. New York: Springer; 2019. p. 497.
-
- Hughes T, Riley RD, Callaghan MJ, Sergeant JC. The value of preseason screening for injury prediction: the development and internal validation of a multivariable prognostic model to predict indirect muscle injury risk in elite football (soccer) players. Sports Med - Open. 2020;6(1):22. doi: 10.1186/s40798-020-00249-8. - DOI - PMC - PubMed
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous